Shots:

• The companies collaborated to develop highly sensitive liquid chromatography-mass spectrometry (LC-MS)-based workflows for advancing blood-based infectious disease detection technology
•  The collaboration leverages NanoPin's diagnostic platform and Thermo Fisher's LC-MS technology to develop clinical assays for infectious disease for determining infection stage and monitor patient response to treatment
• The collaboration may lead to a change in detection & treatment of infectious disease by targeting unmet medical needs of HCPs managing patient care across the globe

Click here ­to­ read full press release/ article | Ref: Thermofisher | Image: Market Watch